Amrinone preconditioning in the isolated perfused rabbit heart

Area of Science:

• Cardiology
• Pharmacology
• Experimental Medicine

Background:

• Ischemic preconditioning (IPC) is known to reduce infarct size in experimental models.
• However, IPC has associated detrimental effects.
• Amrinone was investigated as a potential alternative cardioprotective agent.

Purpose of the Study:

• To evaluate amrinone as a preconditioning agent compared to traditional ischemic preconditioning (IPC).
• To assess the effects of amrinone and IPC on infarct size and cardiac function in an isolated rabbit heart model.

Main Methods:

• Isolated perfused rabbit hearts were treated with amrinone or subjected to IPC before left anterior descending artery occlusion and reperfusion.
• Hemodynamic parameters (left ventricular pressure) and electrophysiological parameters (monophasic action potentials) were monitored.
• Infarct size and incidence of ventricular fibrillation were assessed post-reperfusion.

Main Results:

• Amrinone, unlike IPC, did not reduce peak pressure before occlusion but prevented the rise in end-diastolic pressure during reperfusion.
• Both IPC and amrinone prolonged action potentials beyond preocclusion values after reperfusion.
• Amrinone significantly reduced infarct size and ventricular fibrillation incidence, whereas IPC did not show significant protective effects in this study.

Conclusions:

• Amrinone demonstrates significant cardioprotective effects, reducing infarct size and ventricular fibrillation.
• Amrinone is a superior preconditioning agent compared to traditional ischemic preconditioning (IPC) in this experimental model.
• Amrinone offers a promising alternative for cardioprotection, potentially mitigating the drawbacks of IPC.